Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer

Title
Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer
Authors
Keywords
Pro-opiomelanocortin (<em class=EmphasisTypeItalic >POMC</em>), Non-small cell lung cancer (NSCLC), Prognosis
Journal
TUMOR BIOLOGY
Volume 36, Issue 3, Pages 1811-1817
Publisher
Springer Nature
Online
2014-11-14
DOI
10.1007/s13277-014-2784-1

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started